Respiratory News and Research

RSS

Common weeds may be better than herbal cousins for preventing and curing a host of diseases

Unwanted, pulled or poisoned, the lowly weed is sometimes better than its highly touted “herbal” cousins for preventing and curing a host of diseases, according to University of Florida research.

10 Jun 2004

Study looks at between inhalation of small particles, reduced heart rate variability and death

A study by Oak Ridge National Laboratory and partners might help explain whether there is a relationship between inhalation of small particles, reduced heart rate variability and death.

7 Jun 2004

AMA campaign to stop parents smoking near babies and children

The bib giveaway, launched at King Edward Memorial Hospital today, is the centrepiece of a campaign to encourage parents not to smoke near their baby or children.

2 Jun 2004

Microbes in your gut could be cause of allergies

Allergies making your life miserable? Tired of popping antihistamines like candy? Can't go anywhere without your inhaler? The real problem may not be your stuffed-up head. It could be the microbes in your gut.

1 Jun 2004

Tobacco-related illnesses costs Ilinois $6.7 billion annually

Tobacco-related illnesses take the lives of more than 16,500 Illinois residents each year and cost the state $6.7 billion annually in medical care and lost productivity, according to Dr. Eric E. Whitaker, state public health director.

27 May 2004

Antibiotics could be the cause of many allergies

27 May 2004

New Australian asthma invention provides an incentive for children to inhale their medication correctly

Parents with asthmatic children often experience difficulty with their children resisting medication, particularly using the recommended ‘spacer’ devices which separate the drug dispensing pMDI or ‘puffer’ and the mask through which children inhale their medicine.

26 May 2004

Scientific evidence links mold in homes and buildings to people with chronic asthma symptoms

Scientific evidence links mold and other factors related to damp conditions in homes and buildings to asthma symptoms in some people with the chronic disorder, as well as to coughing, wheezing, and upper respiratory tract symptoms in otherwise healthy people, says a new report from the Institute of Medicine of the National Academies.

25 May 2004

Pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in emergency

A study presented today at the 100th International Conference of the American Thoracic Society in Orlando shows pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in the emergency department (ED) or being admitted into the hospital.

25 May 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Once-daily treatment with Alvesco (ciclesonide) in asthma patients has no effect on normal adrenal function

New data presented at the American Thoracic Society’s 2004 International Conference show that once-daily treatment with the investigational therapy Alvesco (ciclesonide) in mild-to-moderate asthma patients has no effect on normal adrenal function, as demonstrated by measurements of the hypothalamic-pituitary-adrenal (HPA)-axis.

24 May 2004

China commences first clinical test of SARS vaccine

The Xinhuanet Chinese news agency reports that four volunteers are in good health following injections of the world's first clinical test of a severe acute respiratory syndrome (SARS) vaccine.

23 May 2004

Health Canada to tackle human health impacts of air pollution

Health Minister Pierre Pettigrew today announced the Government of Canada is allocating $1 million over the next year to fund cutting-edge research on the human health impacts of air pollution in support of the Georgia Basin/Puget Sound International Airshed Strategy, one of three pilot projects under the Canada-United States Border Air Quality Strategy.

20 May 2004

FDA finalizes new rule on donor eligibility for human tissues and cells

FDA today published a final rule establishing donor eligibility criteria for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) to help prevent the transmission of communicable disease when these products are transplanted.

20 May 2004

Dietary supplement reduces body fat mass in overweight adults by as much as nine percent

A study to be published in the June issue of The American Journal of Clinical Nutrition concludes that the dietary supplement, conjugated linoleic acid (CLA), reduces body fat mass in overweight, but otherwise healthy, adults by as much as nine percent.

20 May 2004

Canadian Statement to the World Health Assembly focuses on AIDS

The WHO's leadership is particularly important in the fight to combat HIV/AIDS. Last week, Canada bolstered its financial commitment to this effort with contributions of $100 million for WHO's '3 by 5 initiative', and $70 million to the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria. Canada and Canadians are proud to take these actions against HIV/AIDS.

19 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Glucose metabolism could be used to selectively destroy cancer cells

Scientists have known for decades that cancer cells consume more glucose than normal cells. A longstanding assumption that the excess glucose metabolism was needed to make energy has not been borne out by research studies.

15 May 2004

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Britannia Pharmaceuticals Limited announced today that U.S.-based Bertek Pharmaceuticals Inc., the branded subsidiary of Mylan Laboratories Inc has received approval from the Food and Drug Administration for APOKYN (apomorphine hydrochloride injection).

13 May 2004

CMS proposed rule that would increase payments to acute care hospitals

The Centers for Medicare & Medicaid Services (CMS) today issued a proposed rule that would increase payments to acute care hospitals for inpatient services in fiscal year 2005

11 May 2004

Respiratory News and Research

Common weeds may be better than herbal cousins for preventing and curing a host of diseases

Study looks at between inhalation of small particles, reduced heart rate variability and death

AMA campaign to stop parents smoking near babies and children

Microbes in your gut could be cause of allergies

Tobacco-related illnesses costs Ilinois $6.7 billion annually

Antibiotics could be the cause of many allergies

New Australian asthma invention provides an incentive for children to inhale their medication correctly

Scientific evidence links mold in homes and buildings to people with chronic asthma symptoms

Pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in emergency

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Once-daily treatment with Alvesco (ciclesonide) in asthma patients has no effect on normal adrenal function

China commences first clinical test of SARS vaccine

Health Canada to tackle human health impacts of air pollution

FDA finalizes new rule on donor eligibility for human tissues and cells

Dietary supplement reduces body fat mass in overweight adults by as much as nine percent

Canadian Statement to the World Health Assembly focuses on AIDS

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Glucose metabolism could be used to selectively destroy cancer cells

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

CMS proposed rule that would increase payments to acute care hospitals

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News